
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.550 | 1.550 | 0.000 |
Stocks | 98.450 | 98.450 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 23.514 | 18.283 |
Price to Book | 5.180 | 3.061 |
Price to Sales | 4.428 | 2.247 |
Price to Cash Flow | 19.114 | 12.317 |
Dividend Yield | 1.511 | 2.027 |
5 Years Earnings Growth | 9.596 | 10.580 |
Name | Net % | Category Average |
---|---|---|
Technology | 28.730 | 23.815 |
Financial Services | 21.100 | 16.698 |
Healthcare | 17.600 | 13.053 |
Consumer Defensive | 16.140 | 7.490 |
Industrials | 7.490 | 11.552 |
Consumer Cyclical | 5.960 | 10.673 |
Communication Services | 2.990 | 7.933 |
Number of long holdings: 43
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 7.77 | 385.76 | -0.53% | |
SAP | DE0007164600 | 7.19 | 232.650 | +1.68% | |
Visa A | US92826C8394 | 6.59 | 336.56 | +0.41% | |
L'Oreal | FR0000120321 | 4.16 | 343.80 | -2.00% | |
Accenture | IE00B4BNMY34 | 4.10 | 289.01 | -0.27% | |
Aon | IE00BLP1HW54 | 4.04 | 381.60 | -0.71% | |
P&G | US7427181091 | 3.33 | 168.79 | -0.20% | |
Abbott Labs | US0028241000 | 3.18 | 125.96 | -1.11% | |
Relx | GB00B2B0DG97 | 3.18 | 3,896.00 | +3.01% | |
Becton Dickinson | US0758871091 | 3.08 | 202.41 | -1.60% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech B USD | 1.37B | 3.28 | 0.99 | 8.87 | ||
Adamant Medtech I USD | 1.37B | 3.45 | 1.70 | 9.65 | ||
EDM Intl S American Growth A USD | 288.68M | 16.42 | -2.50 | 11.74 | ||
LU1811047247 | 207.58M | 4.69 | -10.13 | - | ||
LU1811047593 | 207.58M | 3.96 | -10.76 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review